(Q37962486)

26 August 2017

Metabolic network modeling and simulation for drug targeting and discovery (English)

1 reference

26 August 2017

3

1 reference

26 August 2017

Hyun Uk Kim

1

0 references

author name string

Seung Bum Sohn

series ordinal

2

1 reference

26 August 2017

29 November 2011

1 reference

26 August 2017

Biotechnology Journal

1 reference

26 August 2017

7

1 reference

26 August 2017

3

1 reference

26 August 2017

330-342

1 reference

Human genome 10th anniversary. Will computers crash genomics?

26 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

The implications of human metabolic network topology for disease comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Blueprint for antimicrobial hit discovery targeting metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Systems biology: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Data integration and analysis of biological networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Global reconstruction of the human metabolic network based on genomic and bibliomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Applications of genome-scale metabolic reconstructions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolic reconstruction of the archaeon methanogen Methanosarcina Acetivorans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Large-scale in silico modeling of metabolic interactions between cell types in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale dynamic modeling of the competition between Rhodoferax and Geobacter in anoxic subsurface environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolic modeling of a mutualistic microbial community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Predicting new molecular targets for known drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A human protein-protein interaction network: a resource for annotating the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Constraints-based genome-scale metabolic simulation for systems metabolic engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A protocol for generating a high-quality genome-scale metabolic reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Systems metabolic engineering of Escherichia coli for L-threonine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Fix the antibiotics pipeline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Antibiotics for emerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

An inhibitor of FtsZ with potent and selective anti-staphylococcal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

High-throughput generation, optimization and analysis of genome-scale metabolic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A network-based method for target selection in metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Essential metabolites of Mycobacterium tuberculosis and their mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Multi-targeting by monotherapeutic antibacterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Antibiotics: where did we go wrong?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Functional genomics in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

The impact of transcriptome and proteome analyses on antibiotic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Integrating high-throughput and computational data elucidates bacterial networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A genome-scale computational study of the interplay between transcriptional regulation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Context-specific metabolic networks are consistent with experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Functional integration of a metabolic network model and expression data without arbitrary thresholding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Combinatorial biosynthesis of novel antibiotics related to daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A small-cell lung cancer genome with complex signatures of tobacco exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A reaction-diffusion model of human brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

The Edinburgh human metabolic network reconstruction and its functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Drug off-target effects predicted using structural analysis in the context of a metabolic network model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Predicting metabolic biomarkers of human inborn errors of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale network analysis of imprinted human metabolic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Impact of the solvent capacity constraint on E. coli metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Predicting selective drug targets in cancer through metabolic networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Synergistic drug combinations tend to improve therapeutically relevant selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolic control analysis indicates a change of strategy in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Models from experiments: combinatorial drug perturbations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Prospects for systems biology and modeling of the gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Novel paradigms for drug discovery: computational multitarget screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale reconstruction of Escherichia coli's transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Systems properties of the Haemophilus influenzae Rd metabolic genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale metabolic model of Helicobacter pylori 26695.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

An experimentally validated genome-scale metabolic reconstruction of Klebsiella pneumoniae MGH 78578, iYL1228.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A genome-scale metabolic reconstruction of Mycoplasma genitalium, iPS189

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Metabolic network model of a human oral pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Reconciliation of genome-scale metabolic reconstructions for comparative systems analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Genome-scale reconstruction of the metabolic network in Yersinia pestis, strain 91001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

A genome-scale metabolic model of Cryptosporidium hominis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100159

21 January 2018

Identifiers

DOI

10.1002/BIOT.201100159

1 reference

26 August 2017

1 reference

PubMed ID

22125297